ARCHIVES

ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over

This article is from The Cancer Letter archive.

Vol. 18 No. 29 | July 17, 1992

Download PDF Visit The Full Archive

Related Articles

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Continuing Resolution Funds Agencies Through Dec. 5.

November 17, 2000

Funding Opportunities

October 11, 2002

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999